Produced by AVE, it uses integrated design, easy to operate, and saves laboratory space. The physical, dry chemical, and formed elements test can be completed in one sample aspiration.
Mindray blood cell analysis research and development team launched this product based on stable, accurate and reliable quality.
A recentstudyconcluded that a first-of-its-kind magnetic surgical system allows a safe, reproducible, incision-less technique for port-less intraabdominal mobilization. The Magnetic Surgical System, developed by Levita Magnetics, is so unlik
Medical technology has made inroads in collecting data about health status that were considered impossible just a few short years ago. Automatic recording of data from things such as heart rate to glucose levels can be determined, stored, an
A report from the Landscape Analysis Sub-Group of the Medical Device Innovation Consortium (MDIC),Somatic Variant Reference Samples for NGS, Landscape of Available Reference Samples, compiles all the currently available somatic reference sam
FDA has reported a total of10 medical device recallsso far this year, of which seven were reported in February. Seven recalls in a single month is a lot, but not unheard of. Last year there were a total of 32 medical device recalls, accordin
CareDx said it has filed a patent infringement suit against Natera in the U.S. District Court for Delaware. The Brisbane, CA-based company said it is asserting U.S. Patent Nos. 9,845,497 and 8,703,652, were exclusively licensed to itfrom Sta
Guardant Health is expanding its early cancer detection efforts through a new acquisition. The Redwood City, CA-based firm is set to pick up Bellwether Bio, a private company focused on improving oncology patient care through pioneering rese
Bacillusbacteria detection devices were previously unclassified, known as preamendment devices, since they were in commercial distribution prior to May 28, 1976, when the Medical Device Amendments to the Federal Food, Drug, and Cosmetic Act
PredictImmune announced recently that it has entered a commercial agreement with Addenbrookes Hospital part of Cambridge University Hospitals National Health Service Foundation Trust to provide the companys PredictSure IBD prognostic assay
A new study by Veracyte and collaborators demonstrates that the companys Envisia genomic test can improve the diagnosis of patients being evaluated for interstitial lung disease. The study, published this week in Lancet Respiratory Medicine
Genomic Health reported recently that its fourth quarter revenues rose 22 percent year over year, beating the consensus Wall Street estimate of $101.5 million. For the three months ended Dec. 31, 2018, the companys total revenues were $104.6
Don’t miss important updates about the show and the in vitro diagnostic industry.
Sign-up for our newsletter today.
Copyright © 2026 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.